Finn Gustafsson

Medicin og biovidenskab

1. Heart Failure 100%
2. Heart-Assist Devices 40%
3. Transplant Recipients 30%
4. Heart Transplantation 26%
5. Heart 23%
6. Exercise 23%
7. Hemodynamics 23%
8. Systolic Heart Failure 21%
9. Mortality 19%
10. Brain Natriuretic Peptide 19%
11. empagliflozin 18%
12. Transplants 17%
13. Stroke Volume 15%
14. Everolimus 14%
15. Cardiomyopathies 13%
16. Calcineurin Inhibitors 13%
17. Pulmonary Wedge Pressure 12%
18. Outpatients 12%
19. Randomized Controlled Trials 10%
20. Myocardial Infarction 10%
21. Equipment and Supplies 10%
22. Hospitalization 9%
23. Therapeutics 9%
24. Registries 8%
25. Peripartum Period 8%
26. Survival 8%
27. Kidney 8%
28. Confidence Intervals 8%
29. Cardiology 8%
30. Left Ventricular Dysfunction 8%
31. Atrial Fibrillation 8%
32. Biomarkers 8%
33. Glomerular Filtration Rate 7%
34. Simendan 7%
35. Allografts 7%
36. copeptins 7%
37. Placebos 7%
38. Atrial Pressure 7%
39. Incidence 6%
40. Implantable Defibrillators 6%
41. Quality of Life 6%
42. Left Ventricular Function 6%
43. pro-brain natriuretic peptide (1-76) 6%
44. Pressure 6%
45. Transplantation 6%
46. Natriuretic Peptides 5%
47. Cardiac Catheterization 5%
48. Hyponatremia 5%
49. Sodium Potassium Chloride Symporter Inhibitors 5%
50. Population 5%